GT Biopharma (GTBP) had the highest return between May 1, 2012 and September 30, 2013 by a US stock in the Nasdaq Composite (IXIC), returning 1,415,249,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 5/1/2012 - 9/30/2013 | 1,415,249,900% |
Nutex Health (NUTX) | 5/1/2012 - 9/30/2013 | 499,900.1% |
OLB (OLB) | 5/1/2012 - 9/30/2013 | 28,932.26% |
Nixxy (NIXX) | 5/1/2012 - 9/30/2013 | 20,300% |
TOMI Environmental Solutions (TOMZ) | 5/1/2012 - 9/30/2013 | 2,233.33% |
ACADIA Pharmaceuticals (ACAD) | 5/1/2012 - 9/30/2013 | 1,719.21% |
NextTrip (NTRP) | 5/1/2012 - 9/30/2013 | 1,095.4% |
Xpel (XPEL) | 5/1/2012 - 9/30/2013 | 990.91% |
AlphaTON Capital (ATON) | 5/1/2012 - 9/30/2013 | 934.48% |
Almonty Industries Inc Common Shares (ALM) | 5/1/2012 - 9/30/2013 | 849.8% |
Sarepta Therapeutics (SRPT) | 5/1/2012 - 9/30/2013 | 848.39% |
Supercom (SPCB) | 5/1/2012 - 9/30/2013 | 766.98% |
BioLife Solutions (BLFS) | 5/1/2012 - 9/30/2013 | 695% |
Celldex Therapeutics (CLDX) | 5/1/2012 - 9/30/2013 | 641.21% |
Rezolute (RZLT) | 5/1/2012 - 9/30/2013 | 592.31% |
Ryvyl (RVYL) | 5/1/2012 - 9/30/2013 | 550% |
Genmab A-S (GMAB) | 5/1/2012 - 9/30/2013 | 534.56% |
Addus HomeCare (ADUS) | 5/1/2012 - 9/30/2013 | 527.06% |
Soligenix (SNGX) | 5/1/2012 - 9/30/2013 | 514.71% |
Tesla (TSLA) | 5/1/2012 - 9/30/2013 | 483.66% |
Nexstar Broadcasting (NXST) | 5/1/2012 - 9/30/2013 | 480.57% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2012 - 9/30/2013 | 464.46% |
Mannatech (MTEX) | 5/1/2012 - 9/30/2013 | 447.38% |
Insmed (INSM) | 5/1/2012 - 9/30/2013 | 440.14% |
ZEN Graphene Solutions (ZTEK) | 5/1/2012 - 9/30/2013 | 425.86% |
